newsfilter
← Latest News
GlobeNewswire·

Valneva Announces FDA's Decision to Suspend License of Chikungunya Vaccine IXCHIQ® in the U.S.

Saint Herblain (France), August 25, 2025 – Valneva SE (NASDAQ:VALN, PARIS:VLA), a specialty vaccine company, today announced that the United States Food and Drug Administration (FDA) has suspended the license for